(Q37959147)

25 August 2017

title

Update on the clinical management of atrial fibrillation: guidelines and beyond (English)

1 reference

25 August 2017

0 references

Anne B Curtis

1

1 reference

25 August 2017

language of work or name

English

0 references

publication date

1 November 2011

1 reference

25 August 2017

published in

Postgraduate Medicine

1 reference

25 August 2017

volume

123

1 reference

25 August 2017

issue

6

1 reference

25 August 2017

page(s)

7-20

1 reference

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Increasing prevalence of atrial fibrillation and flutter in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Epidemiology and natural history of atrial fibrillation: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

The burden of atrial fibrillation: should we abandon antiarrhythmic drug therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Atrial fibrillation: public health implications

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Overview of management of atrial fibrillation in symptomatic elderly patients: pharmacologic therapy versus AV node ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Management of newly detected atrial fibrillation: a clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Patterns and predictors of discontinuation of rhythm-control drug therapy in patients with newly diagnosed atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Medical management of atrial fibrillation: state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Likelihood of spontaneous conversion of atrial fibrillation to sinus rhythm

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Asymptomatic atrial fibrillation: demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Atrial fibrillation as a predictive factor for severe stroke and early death in 15,831 patients with acute ischaemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Atrial fibrillation: goals of therapy and management strategies to achieve the goals

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Warfarin use among patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Why do patients with atrial fibrillation not receive warfarin?

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Underutilization of antithrombotic therapy in elderly rural patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Prevalence and quality of warfarin use for patients with atrial fibrillation in the long-term care setting

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Quality of anticoagulation management among patients with atrial fibrillation: results of a review of medical records from 2 communities.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Prevalence of atrial fibrillation and antithrombotic prophylaxis in emergency department patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Effect of clopidogrel added to aspirin in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on Dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Dabigatran versus warfarin in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Apixaban in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Apixaban versus warfarin in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Key issues in the management of atrial fibrillation--protecting the patient and controlling the arrhythmia

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Atrial fibrillation (AF) and heart failure (HF): to treat the AF, be sure to treat the HF.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Identifying patients at high risk for stroke despite anticoagulation: a comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

A review of the literature on atrial fibrillation: rate reversion or control?

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Rhythm or rate control in atrial fibrillation--Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

A comparison of rate control and rhythm control in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Amiodarone versus sotalol for atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Incidence and economic burden of suspected adverse events and adverse event monitoring during AF therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Heart failure and chronic obstructive pulmonary disease the quandary of Beta-blockers and Beta-agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Atrial fibrillation: the newest frontier in arrhythmia management

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Pharmacological rate control of atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). The Dep

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (diamond) substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Dronedarone: a new treatment for atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Effect of dronedarone on cardiovascular events in atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Rhythm- and rate-controlling effects of dronedarone in patients with atrial fibrillation (from the ATHENA trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial [...]

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Increased mortality after dronedarone therapy for severe heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Vernakalant in the management of atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Catheter ablation for atrial fibrillation in congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Upstream therapy of atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Updating the 2006 Guideline)

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a ‘real world’ nationwide cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

Incidence and temporal pattern of hospital readmissions for patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2011.11.2491

21 January 2018

Identifiers

DOI

10.3810/PGM.2011.11.2491

1 reference

25 August 2017

1 reference